Commercial Access Only
Specimen SS-COM-BTR-0397 // BITTER
Receptor Block T5-IV-PH
Brassica napus
Canola/Rapeseed
Receptor Block SeriesTier 5
Target Trait
70
% reduction
Reported target: 70% bitter reduction
Technical Specifications
Genomic Edits
11
GC Content
(54%)
Construct Length
7,860 bp
Promoter System
T7/SP6 cell-free
Expression System
In-vitro cell-free
Host Strain
Cell-free
Pathway Edits
- TAS2R38 complete null
- Glucosinolate complete KO
- Myrosinase suppression
- Palatability enhancer integration
Key Interventions
TAS2R38 null allele integrationFull glucosinolate pathway eliminationMyrosinase suppression cassettePalatability enhancer gene integration
Application Domains
PharmaceuticalResearch
Intended Use
Pharmaceutical excipient and nutraceutical formulation — bitterness-masked brassica extracts and active compounds for clinical and supplement applications
Access
Request Commercial Access
This construct is available exclusively to qualified institutions. Submit an inquiry to receive technical documentation and licensing terms.
Contact Us →No pricing is listed publicly. We respond to all qualified inquiries within 2 business days.